NEWER ANTIMICROBIAL AGENTS HAVING CURRENT OR POTENTIAL CLINICAL APPLICATION.
D000666:Amphotericin B; D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D002512:Cephalothin; D003091:Colistin; D003523:Cycloserine; D003707:Demeclocycline; D004917:Erythromycin; D005839:Gentamicins; D006118:Griseofulvin; D006801:Humans; D007612:Kanamycin; D008712:Methicillin; D009675:Novobiocin; D010068:Oxacillin; D010303:Paromomycin; D010404:Penicillin V / Q000031:analogs & derivatives; D010406:Penicillins / Q000009:adverse effects* / Q000633:toxicity*; D010600:Pharmacology; D012310:Ristocetin; D013203:Staphylococcal Infections; D014116:Toxicology; D014217:Troleandomycin; D014640:Vancomycin
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D005839:Gentamicins; D010406:Penicillins; D012310:Ristocetin; D009675:Novobiocin; D006118:Griseofulvin; D007612:Kanamycin; D003707:Demeclocycline; D010303:Paromomycin; D004917:Erythromycin; D014640:Vancomycin; D000666:Amphotericin B; D003523:Cycloserine; D014217:Troleandomycin; C100209:phenethicillin; D008712:Methicillin; D002512:Cephalothin; D010068:Oxacillin; D010404:Penicillin V; D003091:Colistin
AMPHOTERICIN B; ANTIBIOTICS; ANTIFUNGAL AGENTS; CEPHALOTHIN; COLISTIN; CYCLOSERINE; DEMETHYLCHLORTETRACYCLINE; ERYTHROMYCIN; GENTAMICIN; GRISEOFULVIN; KANAMYCIN; METHICILLIN; NOVOBIOCIN; OXACILLIN; PAROMOMYCIN; PENICILLIN; PENICILLIN TOXICOLOGY; PHARMACOLOGY; PHENETHICILLIN; REVIEW; RISTOCETIN; STAPHYLOCOCCAL INFECTIONS; TOXICOLOGIC REPORT; TRIACETYLOLEANDOMYCIN; VANCOMYCIN